Delineation of liver necrosis using double contrast-enhanced MRI

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 3, 1997, Pages 472-477

  Dupas, Benoît ^a   Bach Gansmo, Tore ^b   Nomballais, Marie Françoise ^a   Meflah, Kahled ^a  

^a HÔTEL DIEU   (France)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Contrast enhancement; Contrast media; Double contrast; Experimental studies; Liver MR; Magnetic resonance (MR)

Indexed keywords

DYSPROSIUM; GADODIAMIDE; GADOLINIUM; GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER NECROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; RAT;

ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DYSPROSIUM; LIVER; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MALE; NECROSIS; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; RADIOGRAPHIC IMAGE ENHANCEMENT; RATS; RATS, INBRED STRAINS; SENSITIVITY AND SPECIFICITY;

EID: 0031401342     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070304     Document Type: Article

References (16)

1. Kennan RP, Zhong J, Gore JC. Intravascular susceptibility contrast mechanisms in tissues. Magn Reson Med 1994; 31: 9-21.
2. Brasch R. New directions in the development ofMR imaging contrast media. Radiology 1992; 183:1-11.
3. Saeed M, Wendland MF, Masui T, Higgins CB. Reperfused myocardial infarction on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 1994; 31:31-39.
4. Saeed M, Wendland MF, Yu KK, Higgins CB. Delineation of acute myocardial infarction with dysprosium DTPA-BMA. Influence of dose of magnetic susceptibility contrast medium. J Am Coll Cardiol 1992; 20:1634-1641.
5. Yu KK, Saeed M, Wendland F, et al. Comparison of T1-enhancing and magnetic susceptibility magnetic resonance contrast agents for demarcation of the jeopardy area in experimental myocardial infarction. Invest Radiol 1993; 28:1015-1023.
6. Sakuma H, O'Sullivan M, Lucas J, et al. Effect of magnetic susceptibility contrast medium on myocardial signal intensity with fast gradient-recalled echo and spin echo MR imaging. Initial experience in human. Radiology 1994; 190:161-166.
7. Nilsson S, Wickström G, Ericsson A, Wickström M, Ksendal A, Waldenström A, Hemmingsson A. Myocardial cell death in reperfused and non reperfused myocardial infarctions. MR imaging with dysprosium DTPA-BMA in the pig. Acta Radiol 1996; 37:18-26.
8. Ericsson A, Bach-Gansmo T, Niklasson F, Hemmingsson A. Combination of gadolinium and dysprosium chelates as a cellular integrity marker in MR imaging. Acta Radiol 1995; 36: 41-46.
9. Wickström M, Martinussen HJ, Ericsson A, Wickström G, Waldenström A, Hemmingsson A. Double contrast enhanced MR imaging of myocardial infarction in the pig. Acta Radiol 1993; 34:64-71.
10. Nilsson S, Wickström G, Ericsson A, et al. Double-contrast MR imaging of reperfused porcine myocardial infarction. Acta Radiol 1996; 37:27-35.
11. Geschwind J-FH, Wendland MF, Saeed M, Lauerma K. Derugin N, Higgins CB. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging. Acta Radiol 1994; 1:319-325.
12. Duckrey H. Genotypes and phenotypes of 10 inbred strains of BD-rats. Arzneimittelforschung 1971; 21:1274-1278.
13. Sironi S, De Cobelli F, Livraghi T, et al. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up. Radiology 1994; 192:407-412.
14. Hemmingsson A, Carlsten J, Ericsson A. et al. MR-cholangiography with double contrast technique. Acta Radiol 1989; 30: 29-33.
15. Suto Y, Shimatani Y. Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma. Br J Radiol 1995; 68:116-120.
16. Mathur-De Vré R, Lemort M. Biophysical properties and clinical applications of magnetic resonance imaging contrast agents. Br J Radiol 1995; 68:225-247.